Dose-response modeling in high-throughput cancer drug screenings: An end-to-end approach

Biostatistics (Oxford, England), 2020.

Cited by: 0|Bibtex|Views82|DOI:https://doi.org/10.1093/biostatistics/kxaa047
WOS
Other Links: arxiv.org|pubmed.ncbi.nlm.nih.gov|academic.microsoft.com

Abstract:

Personalized cancer treatments based on the molecular profile of a patient's tumor are an emerging and exciting class of treatments in oncology. As genomic tumor profiling is becoming more common, targeted treatments for specific molecular alterations are gaining traction. To discover new potential therapeutics that may apply to broad cla...More

Code:

Data:

Full Text
Your rating :
0

 

Tags
Comments